GEN Exclusives

More »

GEN News Highlights

More »
Jul 3, 2007

Panagene Secures License to Commercialize PNA Monomers

  • Panagene licensed the right to sell PNA monomers from the Copenhagen Inventor Group (CIG). The company will synthesize, manufacture, and sell peptide nucleic acids (PNA) monomers.

    Panagene previously obtained exclusive, worldwide license under CIG's patents to PNA custom synthesis. "This license from CIG, in addition to the custom PNA synthesis license already granted, shows our continued commitment to expand the field of PNA research," says Sung Kee Kim, Ph.D., president and CEO of Panagene.

    Panagene estimates the PNA market today to be approximately 5% of the DNA/RNA synthesis market but believes that this license will help it grow the business.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?